Kammerl M C, Nüsing R M, Seyberth H W, Riegger G A, Kurtz A, Krämer B K
Institut für Physiologie 1, University of Regensburg, Germany.
Pflugers Arch. 2001 Sep;442(6):842-7. doi: 10.1007/s004240100616.
This study aimed to assess the impact of cyclooxygenase-2 (COX-2) on the secretion and expression of renin in the kidney cortex. For this purpose renocortical COX-2 expression was moderately stimulated by a low-salt diet or strongly stimulated (increase in mRNA about fivefold) by the combination of a low-salt diet and the angiotensin-I-converting enzyme inhibitor ramipril in male Sprague-Dawley rats. None of these manoeuvres changed medullary COX-2 expression or cortical or medullary COX-1 expression. Treatment with low salt plus ramipril but not with low salt alone led to a three- to fourfold increase of the urinary output of all major prostanoids. The selective COX-2 inhibitor rofecoxib (10 mg/kg per day) markedly lowered basal urinary prostanoid excretion and blunted the stimulation of prostanoid excretion during treatment with low salt plus ramipril. The stimulation of renin secretion by the low-salt diet but not by low salt plus ramipril was attenuated by rofecoxib. The low-salt diet led to a moderate increase of renin gene expression, and additional treatment with ramipril caused a 15-fold increase of renin mRNA. However, no effect of rofecoxib on renin gene expression was observed in any group. These findings suggest that stimulation of COX-2 in the renal cortex leads to the increased formation of all major prostanoids. COX-2-derived prostanoids may play a role in the regulation of renin secretion but not in renin gene expression during the intake of a low-salt diet. However, no major relevance of COX-2-derived prostanoids to renin secretion or renin gene expression during ramipril treatment or a combination of ramipril and a low-salt diet was found.
本研究旨在评估环氧化酶-2(COX-2)对肾皮质中肾素分泌和表达的影响。为此,在雄性Sprague-Dawley大鼠中,低盐饮食适度刺激肾皮质COX-2表达,而低盐饮食与血管紧张素-I转换酶抑制剂雷米普利联合使用则强烈刺激(mRNA增加约五倍)。这些操作均未改变髓质COX-2表达或皮质或髓质COX-1表达。低盐加雷米普利治疗而非单独低盐治疗导致所有主要前列腺素的尿量增加三到四倍。选择性COX-2抑制剂罗非昔布(每天10 mg/kg)显著降低基础尿前列腺素排泄,并减弱低盐加雷米普利治疗期间前列腺素排泄的刺激。罗非昔布减弱了低盐饮食而非低盐加雷米普利对肾素分泌的刺激。低盐饮食导致肾素基因表达适度增加,雷米普利的额外治疗使肾素mRNA增加15倍。然而,在任何组中均未观察到罗非昔布对肾素基因表达的影响。这些发现表明,肾皮质中COX-2的刺激导致所有主要前列腺素的生成增加。COX-2衍生的前列腺素可能在低盐饮食摄入期间对肾素分泌的调节中起作用,但对肾素基因表达无作用。然而,未发现COX-2衍生的前列腺素在雷米普利治疗期间或雷米普利与低盐饮食联合使用期间对肾素分泌或肾素基因表达有主要影响。